Literature DB >> 26482820

Erlotinib-related rhabdomyolysis: the role of pharmacogenetics and drug-drug interaction.

Marta Koršić1, Davorka Muršić2, Sonja Badovinac3, Nada Božina4, Mihovil Roglić5, Marko Jakopović6, Branka Čučević7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26482820     DOI： 10.1007/s00280-015-2885-6

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  2 in total

1.  Dasatinib-Induced Rhabdomyolysis in a 33-Year-Old Patient with Chronic Myeloid Leukemia.

Authors:  Andrew Stevenson Joel Chandranesan; Samip Master; Olivia Antosz; Breanne PeytonThomas; Nebu Koshy
Journal:  Case Rep Hematol       Date:  2018-05-06

2.  Rhabdomyolysis Caused by Gefitinib Overdose.

Authors:  Shohei Obayashi; Katsuyoshi Tomomatsu; Mika Urata; Jun Tanaka; Kyoko Niimi; Naoki Hayama; Tsuyoshi Oguma; Koichiro Asano; Yoko Ito
Journal:  Intern Med       Date:  2021-10-26       Impact factor: 1.282
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.